Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs CRL✓SelectedUSD · CRLGSK vs CRL performance historyLatest closeAs of-0.08%11/16
Stock and ETF performance explorer

GSK vs CRL

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+64.4%
CRL return
+78.4%
Excess return
-14.1%
Maximum drawdown
-28.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioCRLExcessAlpha
1D-0.1%-0.7%+0.6%0.0%
7D-1.3%-5.0%+3.7%-0.9%
30D+2.7%+11.8%-9.0%+1.3%
3M+2.7%+19.8%-17.1%+0.4%
6M+3.3%+122.4%-119.1%-5.5%
YTD+6.5%+68.2%-61.7%-0.2%
1Y+10.7%+99.9%-89.3%+1.6%
3Y+64.4%+77.0%-12.6%+47.5%
All+64.4%+78.4%-14.1%+47.5%

Cumulative growth

Daily Returns

Daily percentage return beside CRL.

Daily Out/Under-Performance

Portfolio return minus CRL return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × CRL return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded CRL wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling